ATOPIC DERMATITIS

This study tested a drug called LY3454738 in 234 adults with moderate-to-severe atopic dermatitis (eczema). The goal was to see if it safely reduces skin redness, swelling, and itching. Participants received either the drug or a placebo for 52 weeks. The trial was stopped early, …

This study tested a new medicine called SAR444656 for adults with moderate to severe eczema that wasn't helped by creams. About 70 people were randomly assigned to get one of three doses of the drug or a placebo for 16 weeks. The goal was to see if the drug could reduce eczema se…

This study tested an experimental daily pill called RPT193 in 229 adults with moderate-to-severe atopic dermatitis (eczema) that didn't improve with topical creams. The goal was to see if the pill could reduce eczema severity over 16 weeks. The trial was ended early, so results a…

This early-stage study aimed to test the safety of a new drug called LY3872386 in healthy volunteers and people with atopic dermatitis (eczema). The study was terminated early, so no meaningful results are available. Only 18 participants were planned, and the drug's effects on ec…

This study tested a new drug called NM26-2198 for moderate-to-severe eczema (atopic dermatitis). It included healthy volunteers and patients, giving single or multiple doses to check safety and how the body processes the drug. The trial was terminated early, so results are limite…

This study tested an experimental drug called IMG-007 in 13 adults with moderate-to-severe eczema (atopic dermatitis) who didn't get enough relief from topical treatments. The main goal was to check the drug's safety, and researchers also looked at how the body processes it and w…

This study tested a new drug called XmAb27564 in 23 people with plaque psoriasis or atopic dermatitis (eczema). The main goal was to see if the drug is safe and tolerable when given as multiple injections. The trial was stopped early, and results are not yet available.

This study tested whether a probiotic mixture could help treat atopic dermatitis (eczema) in children aged 6 months to 3 years. The goal was to see if it reduced eczema severity, the need for steroid creams, and was safe. Only 4 children enrolled before the study was stopped earl…

This study tested a cream called ruxolitinib on adults with eczema (atopic dermatitis) who had trouble sleeping because of their condition. The goal was to see if the cream could improve total sleep time using a wearable ring device. The study was stopped early, but it involved 4…

This study looked at babies under 6 months old with eczema to find out how they show discomfort, since they are too young to scratch or talk. Researchers filmed the babies and recorded their behaviors to better understand their itch and pain. The goal was to improve how doctors a…

This study looked at how the drug tralokinumab affects the skin of people with moderate to severe eczema. Researchers measured drug levels in skin samples after 16 weeks of treatment. The goal was to better understand how the drug works, which could help doctors choose the right …

This early-stage study tested a new oral drug called IPG7236 in 63 healthy adults to see if it was safe and how the body processes it. The study was terminated before any results could be gathered. Because it only involved healthy volunteers, it does not provide information on wh…

This study aimed to better understand the causes of eczema and compare two types of light therapy (broadband vs narrowband UVB) to see which works better. Researchers planned to enroll 69 people with moderate-to-severe eczema across three Canadian centers. The study was terminate…